Amodiaquine Tablets

  • Product Name : Amodiaquine Tablets
  • Trade Name : Amdaquine, Amobin
  • Available Strength : 200 mg
  • Available Combination : Amodiaquine + Artesunate Tablets
  • Packing : 10X10 tablet/box
  • Pack Insert/Leaflet : Yes
  • Therapeutic use : Antimalarial
  • Production Capacity : 10 million tablet/month
Request A Quote


What is Amodiaquine?
The salt Amodiaquine is used for the treatment of Malarial Infections and other conditions.Detailed information related to Amodiaquine’s uses, side-effects, reviews, questions, interactions, and precautions is as follows:

Amodiaquine Uses
Amodiaquine is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

  • Malarial Infections

Amodiaquine Working, Mechanism of Action and Pharmacology
Amodiaquine improves the patient’s condition by performing the following functions:

  • Altering the membrane function of malarial parasites.

Amodiaquine – Side-effects
The following is a list of possible side effects that may occur in medicines that contain Amodiaquine. This is not a comprehensive list. These side effects are possible, but do not always occur. Some of the side effects may be rare but serious. Consult your doctor if you observe any of the following side effects, especially if they do not go away.

  • Weakness
  • Nausea
  • Vomiting
  • Itching
  • Stomach Pain
  • Loss Of Appetite

Amodiaquine – Precautions & How to Use
Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

  • Do not use injectable form in children below 5 years
  • G6PD deficiency
  • Ophthalmic examination required during prolonged therapy
  • Peripheral neuropathy

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

ASIA: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.

AFRICA: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.

NORTH & SOUTH AMERICA: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .

EUROPE: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA: Australia, New Zealand, Fiji, and so forth.